According to the most recent financial data from September 2025, the EPS for the trailing twelve months is $0.97. Bausch Health Companies's EPS for 2024 amounted to -$0.13, marking an increase from -$1.62 in 2023. During the quarterly period ending on Sep 30, 2025, BHC's EPS stood at $0.48.
Bausch Health Companies had an annual EPS of -$0.13, indicating an increase of 92% from -$1.62 in 2023. The quarterly per-share earnings for the period ending Sep 30, 2025, was $0.48, indicating a 308.7% increase from the same quarter last year. BHC's 12-month EPS stands at $0.97 as of September 2025. Bausch Health Companies's annual EPS in 2023 stood at -$1.62, a 161.3% decrease year-over-year.
Bausch Health Companies has registered an increase in EPS of 308.7% during the last 12 months (YoY, quarterly).
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| BHC Bausch Health Companies Inc | 6.99 | 92% | N/A | N/A |
| OPK Opko Health Inc | N/A | 68% | N/A | N/A |
| ORGO Organogenesis Holdings Inc | N/A | -125% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.